Assays With Pediatric Settings

New clinical chemistry assays have pediatric settings designed to enable clinicians to obtain a full-result profile the first time, without having to prioritize because of the small size of the sample.

The new pediatric settings are available from the diagnostics division of Olympus Life and Material Science Europa GmbH (Hamburg, Germany) and they have received the CE Mark. The settings are available for the complete range of Olympus analyzers: the AU400, AU600/AU640, and AU2700/AU5400.

The range of settings includes 22 analytes: albumin, ALP (2), ALT, AST, bicarbonate, bilirubin direct, bilirubin total, calcium (2), creatinine, C3, C4, GGT, glucose, IgM, iron, LDH (2), transferrin, triglyceride, and urea.

The new settings also reduce sampling that can be unnecessary or stressful in newborns or children. The problem of being able to obtain only a small sample is not confined to pediatric patients. The increasing number of geriatric patients in the healthcare system presents similar problems, such as shrunken or broken veins. Chemotherapy patients may have large numbers of puncture sites.

"We therefore see there being wide potential for using these low-volume settings by customers and thus both increasing test profiling capabilities and reducing patient distress,” said Dr. Christoph Mauracher, of Olympus.

The Diagnostics Division of Olympus provides in vitro diagnostic products for clinical chemistry, electrophoresis, and pre-transfusion testing.




Related Links:
Olympus Life and Material Science Europa GmbH